Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation

NCT04089631 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

4812

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer Stage II

Interventions

DRUG: Capecitabine

Sponsor

Technische Universität Dresden